Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation
Open Access

The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability

Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G. Schwarz, David T. Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen and Val J. Lowe
Journal of Nuclear Medicine November 2022, 63 (11) 1748-1753; DOI: https://doi.org/10.2967/jnumed.121.263136
Jeyeon Lee
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Burkett
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hoon-Ki Min
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily S. Lundt
2Department of Health Sciences Research, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina M. Albertson
2Department of Health Sciences Research, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugo Botha
3Department of Neurology, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew L. Senjem
4Department of Information Technology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey L. Gunter
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher G. Schwarz
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David T. Jones
3Department of Neurology, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. Knopman
3Department of Neurology, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifford R. Jack Jr.
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald C. Petersen
3Department of Neurology, Rochester, Minnesota; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val J. Lowe
1Department of Radiology, Rochester, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    OI calculation. OI was designed to identify voxels with stable high activity over time using 2 consecutive tau PET scans.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Examples of low OI and high OI. Three consecutive 3-dimensional scatterplots are displayed in each box for 4 different examples, representing tau PET SUVR of each voxel in each scan from individual subject. (A) Low-OI cases. (B) High-OI cases. Below each rendering, median SUVR represents median value for all voxels in each region. Color bar indicates intensity of each voxel. Font color of median SUVR is red when >1.29 and blue when <1.29. Arrows in B indicate regions showing spatial consistency. Various anatomic regions are plotted and labeled in each panel.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Relationship between OI and baseline SUVR in single ROI. Bilateral ROIs were included in calculations. Small panel inside figure illustrates enlarged view of lower SUVR range (from 0.9 to 1.5).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Relationship between meta-ROI OI and meta-ROI SUVR. (A) Scatterplot (left) of baseline SUVR and OI for meta-ROI. Histograms are displayed along SUVR and OI axis, respectively. Low SUVR range (<1.5) was magnified in separate scatterplot (right) with linear regression (solid black line) and 95% confidence band (dotted black lines). (B) Scatterplot of meta-ROI OI and ΔSUVR with regression. (C) Comparison of ΔSUVR between SUVR-based subgroups. (D) SUVR-based subgroups in C were further separated into low-OI and high-OI categories. *P < 0.05, post hoc Dunn tests. **P < 0.05, post hoc Dunn tests. ***P < 0.005, post hoc Dunn tests.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Association of OI with disease progression. (A) Tau PET variables in different clinical groups. OI, baseline SUVR, baseline SUVR with partial-volume correction (SUVRpvc), and ΔSUVR from meta-ROI of CUA− to CUA− were compared with those of other groups. *P < 0.05, post hoc Dunn tests. **P < 0.05, post hoc Dunn tests. ***P < 0.005, post hoc Dunn tests.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Result for ADNI cohort. (A) Scatterplot of baseline SUVR and OI for meta-ROI. (B) Comparison of ΔSUVR between SUVR-based subgroups. (C) SUVR-based subgroups in B were further separated into low-OI and high-OI categories. (D) OI, baseline SUVR, and ΔSUVR from meta-ROI of CUA− to CUA− were compared with those of other groups. *P < 0.05, post hoc Dunn tests. **P < 0.05, post hoc Dunn tests. ***P < 0.005, post hoc Dunn tests.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (11)
Journal of Nuclear Medicine
Vol. 63, Issue 11
November 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability
Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G. Schwarz, David T. Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen, Val J. Lowe
Journal of Nuclear Medicine Nov 2022, 63 (11) 1748-1753; DOI: 10.2967/jnumed.121.263136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability
Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G. Schwarz, David T. Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen, Val J. Lowe
Journal of Nuclear Medicine Nov 2022, 63 (11) 1748-1753; DOI: 10.2967/jnumed.121.263136
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test
  • Google Scholar

More in this TOC Section

  • SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
  • Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein–Targeted Imaging—FAP-RADS Version 1.0
  • Imaging Efficacy of [18F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study
Show more Clinical Investigation

Similar Articles

Keywords

  • AV-1451
  • flortaucipir
  • tau PET
  • variability
  • early detection
SNMMI

© 2025 SNMMI

Powered by HighWire